325 related articles for article (PubMed ID: 32194251)
1. Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial.
Socias ME; Wood E; Dong H; Brar R; Bach P; Murphy SM; Fairbairn N
Contemp Clin Trials; 2020 Apr; 91():105993. PubMed ID: 32194251
[TBL] [Abstract][Full Text] [Related]
2. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
Beck T; Haasen C; Verthein U; Walcher S; Schuler C; Backmund M; Ruckes C; Reimer J
Addiction; 2014 Apr; 109(4):617-26. PubMed ID: 24304412
[TBL] [Abstract][Full Text] [Related]
3. Slow-release oral morphine as maintenance therapy for opioid dependence.
Ferri M; Minozzi S; Bo A; Amato L
Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540
[TBL] [Abstract][Full Text] [Related]
4. Maintenance agonist treatments for opiate-dependent pregnant women.
Minozzi S; Amato L; Jahanfar S; Bellisario C; Ferri M; Davoli M
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006318. PubMed ID: 33165953
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
[TBL] [Abstract][Full Text] [Related]
6. The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.
Socias ME; Ahamad K; Le Foll B; Lim R; Bruneau J; Fischer B; Wild TC; Wood E; Jutras-Aswad D
Contemp Clin Trials; 2018 Jun; 69():21-27. PubMed ID: 29627621
[TBL] [Abstract][Full Text] [Related]
7. Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study.
Verthein U; Beck T; Haasen C; Reimer J
Eur Addict Res; 2015; 21(2):97-104. PubMed ID: 25427944
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.
Hämmig R; Köhler W; Bonorden-Kleij K; Weber B; Lebentrau K; Berthel T; Babic-Hohnjec L; Vollmert C; Höpner D; Gholami N; Verthein U; Haasen C; Reimer J; Ruckes C
J Subst Abuse Treat; 2014 Oct; 47(4):275-81. PubMed ID: 25064422
[TBL] [Abstract][Full Text] [Related]
9. Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine.
Lehmann K; Kuhn S; Baschirotto C; Jacobsen B; Walcher S; Görne H; Backmund M; Scherbaum N; Reimer J; Verthein U
J Subst Abuse Treat; 2021 Aug; 127():108350. PubMed ID: 34134867
[TBL] [Abstract][Full Text] [Related]
10. Maintenance agonist treatments for opiate-dependent pregnant women.
Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
[TBL] [Abstract][Full Text] [Related]
11. Slow release oral morphine versus methadone for the treatment of opioid use disorder.
Klimas J; Gorfinkel L; Giacomuzzi SM; Ruckes C; Socías ME; Fairbairn N; Wood E
BMJ Open; 2019 Apr; 9(4):e025799. PubMed ID: 30944135
[TBL] [Abstract][Full Text] [Related]
12. Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care.
Baschirotto C; Lehmann K; Kuhn S; Reimer J; Verthein U
J Pharmacol Sci; 2020 Sep; 144(1):9-15. PubMed ID: 32586692
[TBL] [Abstract][Full Text] [Related]
13. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
Bond AJ; Reed KD; Beavan P; Strang J
Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and quality of life of opioid-dependent pregnant women in Austria.
Metz VE; Comer SD; Wuerzl J; Pribasnig A; Fischer G
Arch Womens Ment Health; 2014 Dec; 17(6):529-39. PubMed ID: 25023716
[TBL] [Abstract][Full Text] [Related]
15. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
Falcato L; Beck T; Reimer J; Verthein U
J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
[TBL] [Abstract][Full Text] [Related]
16. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with slow-release oral morphine following afentanyl-related overdose: A case report.
Prinsloo G; Ahamad K; Socías ME
Subst Abus; 2019; 40(4):473-475. PubMed ID: 30829174
[No Abstract] [Full Text] [Related]
18. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence.
Mitchell TB; White JM; Somogyi AA; Bochner F
Addiction; 2004 Aug; 99(8):940-5. PubMed ID: 15265090
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
[TBL] [Abstract][Full Text] [Related]
20. Initiation and rapid titration of methadone and slow-release oral morphine (SROM) in an acute care, inpatient setting: a case series.
Rodger L; Nader M; Turner S; Lurie E
Eur J Med Res; 2023 Dec; 28(1):573. PubMed ID: 38066517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]